The Cooper Companies, Inc. $COO Shares Sold by Generation Investment Management LLP

Key Points

• Generation Investment Management LLP reduced its stake in The Cooper Companies, Inc. by 26.9%, now holding approximately 2.87 million shares, making it the fund's 22nd largest holding.
• In the latest quarter, Cooper Companies reported earnings of $1.10 per share, surpassing the consensus estimate of $1.07, with revenue of $1.06 billion.
• Various institutional investors are showing increased confidence, with firms such as EP Wealth Advisors LLC and Twin Tree Management LP substantially increasing their holdings in Cooper Companies.

Generation Investment Management LLP lowered its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 26.9% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,873,376 shares of the medical device company's stock after selling 1,060,002 shares during the period. Cooper Companies comprises approximately 1.5% of Generation Investment Management LLP's investment portfolio, making the stock its 22nd biggest position. Generation Investment Management LLP owned approximately 1.44% of Cooper Companies worth $242,369,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Zions Bancorporation National Association UT acquired a new position in shares of Cooper Companies during the 1st quarter worth approximately $33,000. City Holding Co. purchased a new position in Cooper Companies during the first quarter valued at $34,000. GKV Capital Management Co. Inc. acquired a new stake in shares of Cooper Companies in the first quarter valued at about $40,000. Larson Financial Group LLC increased its stake in shares of Cooper Companies by 1,071.0% during the first quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock worth $61,000 after purchasing an additional 664 shares in the last quarter. Finally, HM Payson & Co. raised its position in shares of Cooper Companies by 147.4% during the 1st quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock worth $75,000 after purchasing an additional 532 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company's stock.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, COO Gerard H. Warner III bought 1,450 shares of the business's stock in a transaction dated Friday, September 5th. The shares were acquired at an average cost of $69.23 per share, with a total value of $100,383.50. Following the acquisition, the chief operating officer directly owned 18,319 shares of the company's stock, valued at $1,268,224.37. The trade was a 8.60% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Daniel G. Mcbride purchased 3,000 shares of the firm's stock in a transaction that occurred on Tuesday, September 2nd. The shares were acquired at an average price of $65.04 per share, with a total value of $195,120.00. Following the purchase, the chief operating officer owned 63,120 shares in the company, valued at $4,105,324.80. This trade represents a 4.99% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have acquired 15,975 shares of company stock valued at $1,079,566. 1.98% of the stock is currently owned by insiders.

Cooper Companies Stock Up 0.1%

COO stock traded up $0.09 during trading on Friday, hitting $68.09. 2,759,386 shares of the company's stock were exchanged, compared to its average volume of 2,951,187. The stock has a market capitalization of $13.54 billion, a price-to-earnings ratio of 33.54, a PEG ratio of 1.72 and a beta of 0.97. The Cooper Companies, Inc. has a 52-week low of $61.78 and a 52-week high of $112.38. The company has a current ratio of 2.12, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. The business has a 50-day moving average price of $71.99 and a two-hundred day moving average price of $76.72.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, topping the consensus estimate of $1.07 by $0.03. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The firm had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.06 billion. During the same period last year, the business earned $0.96 EPS. Cooper Companies's revenue for the quarter was up 5.7% compared to the same quarter last year. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, equities research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Ratings Changes

A number of brokerages have commented on COO. JPMorgan Chase & Co. reduced their target price on Cooper Companies from $76.00 to $66.00 and set a "neutral" rating for the company in a report on Thursday, August 28th. BNP Paribas Exane upgraded shares of Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 target price for the company in a research report on Tuesday, July 22nd. Robert W. Baird decreased their price target on shares of Cooper Companies from $97.00 to $85.00 and set an "outperform" rating on the stock in a research note on Thursday, August 28th. BNP Paribas raised Cooper Companies from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, July 22nd. Finally, Needham & Company LLC reiterated a "buy" rating and issued a $94.00 price objective on shares of Cooper Companies in a research report on Thursday, August 28th. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have given a Hold rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $86.64.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.